ARTICLE | Clinical News
Serdolect sertindole regulatory update
May 2, 2005 7:00 AM UTC
CHMP recommended removing the marketing restrictions on Serdolect sertindole to treat schizophrenia. In 2000, the EC suspend the marketing authorization for Serdolect in Europe after the Netherlands s...